Results 271 to 280 of about 258,151 (309)

SERIAL PROSTATE SPECIFIC ANTIGEN, FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN RATIO AND COMPLEXED PROSTATE SPECIFIC ANTIGEN FOR THE DIAGNOSIS OF PROSTATE CANCER

THE JOURNAL OF UROLOGY, 2001
The free-to-total prostate specific antigen (PSA) ratio and complexed PSA have been introduced as adjuncts to total PSA for prostate cancer screening. Little data exist on the use of these tests for serial PSA screening. We compared serial total PSA, the free-to-total PSA ratio and calculated complexed PSA in men diagnosed with prostate cancer and ...
W J, Ellis, R, Etzioni, R L, Vessella, C, Hu, G E, Goodman   +4 more
openaire   +2 more sources

The prostate-specific antigen test

Expert Opinion on Medical Diagnostics, 2013
Before the 1980s, prostate cancer (PC) was considered a deadly disease. The mortality-incidence ratio showed that 1 out of each 2 - 3 PC patients died of this disease. On the other hand, autopsy studies have shown that latent PC is common in middle-aged men.
openaire   +3 more sources

Purification of a human prostate specific antigen

Journal of Urology, 2002
Rabbit antiserum raised against the crude extract of normal human prostatic tissue contained antibodies to a prostatic tissue-specific antigen as shown by immunoprecipitation techniques. Using this antiserum a prostate antigen was detected in normal, benign hypertrophic, and malignant prostatic tissues, but not in other human tissues.
M C, Wang, L A, Valenzuela, G P, Murphy, T M, Chu   +3 more
openaire   +3 more sources

PREDICTING PROSTATE SPECIFIC ANTIGEN OUTCOME PREOPERATIVELY IN THE PROSTATE SPECIFIC ANTIGEN ERA

Journal of Urology, 2001
We evaluated the ability of previously defined risk groups to predict prostate specific antigen (PSA) outcome 10 years after radical prostatectomy in patients diagnosed with clinically localized prostate cancer during the PSA era.Between 1989 and 2000, 2,127 men with clinically localized prostate cancer underwent radical prostatectomy, including 1,027 ...
A V, D'Amico, R, Whittington, S B, Malkowicz, M, Weinstein, J E, Tomaszewski, D, Schultz, M, Rhude, S, Rocha, A, Wein, J P, Richie   +9 more
openaire   +2 more sources

Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression

Current Urology Reports, 2007
Benign prostatic hyperplasia (BPH) is the most common urologic affliction in aging men, leading to adverse clinical outcomes in a significant proportion of the population. Serum prostate-specific antigen (PSA) has been established as a marker for prostate cancer for the past two decades but more recently has been recognized as an equally important ...
Jonathan M, Levitt, Kevin M, Slawin
openaire   +2 more sources

Prostate-specific antigen and screening for prostate cancer

Medical Clinics of North America, 2004
This article discusses prostate-specific antigen (PSA) and screening for prostate cancer. Topics explored include the history of PSA testing, the biology of PSA, clinical uses of PSA testing, improving the accuracy of PSA testing, and controversies in prostate cancer screening.
Misop, Han, Peter H, Gann, William J, Catalona   +2 more
openaire   +2 more sources

Prostate-specific antigen as a marker of adenocarcinoma of prostate

Urological Research, 1989
Prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) serum levels were measured in 117 patients with prostatic adenocarcinoma, in 9 patients with prostatic hyperplasia and in 14 patients with other malignancies to compare the clinical usefulness of the PSA and PAP levels. PSA was elevated (PSA+) in 14 of 18 untreated patients (78%) with
P, Kellokumpu-Lehtinen, M, Nurmi, P, Koskinen, K, Irjala   +3 more
openaire   +2 more sources

Prostate-specific antigen vaccines for prostate cancer

Expert Opinion on Biological Therapy, 2002
Prostate cancer is the most common malignant tumour in men and there are few treatment options available once the tumour becomes refractory to hormonal manipulation. Prostate-specific antigen (PSA) is a secretory glycoprotein that is commonly expressed by prostatic epithelial cells and is found in elevated levels in the serum of men with prostate ...
Heidi, Hörig, Christopher S D, Lee, Howard L, Kaufman   +2 more
openaire   +2 more sources

Evaluation of Prostate-Specific Antigen in Prostate Cancer

American Journal of Clinical Oncology, 1988
Prostate-specific antigen (PSA) was assayed retrospectively in 131 prostate cancer patients. Pretreatment levels at primary tumor diagnosis were above 5 ng/ml in 13/16 (81%) of stage B and C patients and in 28/28 (100%) of stage D (D1 and D2) patients.
D, Pons-Anicet, A, Ramaioli, M, Namer, B P, Krebs   +3 more
openaire   +2 more sources

Prostatic intraepithelial neoplasia and prostate-specific antigen

World Journal of Urology, 1993
Prostatic intraepithelial neoplasia (PIN) is a putative premalignant lesion of the prostate gland. PIN has been demonstrated to share morphologic and phenotypic similarities to invasive carcinoma of the prostate. In addition, PIN is spatially related to invasive carcinoma and occurs with greater frequency in men whose prostates harbor carcinoma ...
J R, Porter, M K, Brawer
openaire   +2 more sources